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HYPONATREMIA IN VISCERAL LEISHMANIASIS
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SUMMARY
There are few reports linking hyponatremia and visceral leishmaniasis (kala-azar). This is a study of 55 consecutive kala-azar 
patients and 20 normal individuals as a control group. Hyponatremia and serum hypo-osmolality were detected in 100% of kala-
azar patients. High first morning urine osmolality (750.0 ± 52.0 vs. 894.5 ± 30.0mOsm/kg H2O, p < 0.05), and high 24-hour urine 
osmolality (426.0 ± 167.0 vs. 514.6 ± 132.0 mOsm/kg H2O, p < 0.05) demonstrated persistent antidiuretic hormone secretion. Urinary 
sodium was high (82.3 ± 44.2 vs.110.3 ± 34.7 mEq/L, p < 0.05). Low seric uric acid occurred in 61.8% of patients and increased 
fractional urinary uric acid excretion was detected in 74.5% of them. Increased glomerular filtration rate was present in 25.4% of 
patients. There was no evidence of extracellular volume depletion. Normal plasma ADH levels were observed in kala-azar patients. 
No endocrine or renal dysfunction was detected. It is possible that most hyponatremic kala-azar patients present the syndrome of 
inappropriate antidiuretic hormone secretion. 
KEYWORDS: Hyponatremia; Hypo-osmolality; Hypouricemia; Syndrome of inappropriate antidiuretic hormone secretion; Visceral 
leishmaniasis.
INTRODUCTION
Visceral leishmaniasis (kala-azar) is a zoonosis that affects 
predominantly young people, and which has extensive public health 
impact in tropical and subtropical regions of the world. It is estimated, 
that more than 12 million individuals are infected by various Leishmania 
species in 88 countries, with an estimated 1.5 to 2 million clinical 
cases4. The visceral form of the disease, fatal if not treated, is caused 
in Brazil by Leishmania donovani chagasi, species associated with 
endemic outbreaks. Kala-azar causes an intense immune dysfunction 
with polyclonal activation of B lymphocytes and depression in cellular 
and humoral immunities10. Visceral leishmaniasis progresses with intense 
inflammatory alterations in vital organs such as the lungs, liver, spleen, 
kidneys, digestive tract and bone marrow. Interstitial pneumonitis is 
common during the active phase of the disease, and necropsy studies 
have shown the prevalence of interstitial pneumonitis to be around 
76.8% of human cases. A dry cough is a constant symptom of kala-azar, 
that persists from the onset of the disease throughout its entire clinical 
course. The parasitary etiology of the pneumonitis can be confirmed 
by immunohistochemical reaction using anti-leishmania polyclonal 
specific anticorps12. Lobar pneumonia is a frequent complication of more 
debilitated patients, when secondary pulmonary bacterial infections 
occur. In a study involving 50 children with kala-azar, the diagnostic of 
lobar pneumonia occurred in 10% of cases and Staphylococcus aureus 
and Streptococcus pneumoniae were the most frequent etiologic agents36. 
Hyponatremia has been decribed in children with visceral leishmaniasis25 
and prospective studies of patients with chronic forms of kala-azar have 
shown the presence of hyponatremia and high daily sodium urinary 
excretion, characteristics that persist during all active phases of the 
disease20,21, returning to normal serum levels after glucantime treatment. 
Hyponatremia and high sodium urinary excretion are features of the 
syndrome of innapropriate antidiuretic hormone secretion, of adrenal 
insufficiency or carriers of renal sodium wasting diseases5,15. 
The aim of the present study is to describe the characteristics of the 
hyponatremia observed in chronic forms of kala-azar. 
PATIENTS AND METHODS
This study included 55 patients admitted to Hospital São José de 
Doenças Infecciosas and to the Hospital Geral de Fortaleza between 
2002 and 2008. Diagnosis of kala-azar was confirmed by the finding of 
L. donovani, subspecie chagasi in bone marrow smears. Patients with 
arterial hypertension, systemic diseases and history of renal diseases are 
excluded. HIV positive patients or that having specific pulmonar diseases 
do not participate from the investigation. Patients with decreased renal 
function (Ccr<85mL/min/1.73m2) were rejected because the possibility 
of alterations of extracellular volume of these patients. Thirteen patients 
were excluded because they did not satisfy the criteria of the present 
investigation. All patients received a hospital diet with 2g/kg body 
weight of animal protein and a daily ingestion of 10 to 12g of sodium 
chloride. No medication was administered during the study period, and 
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only physical measures were used to fever control. All patients were from 
the rural zones and were diagnosed as having had daily fever for several 
weeks, increased abdominal volume and great hepatosplenomegaly. No 
patient had received kala-azar treatment previously. All patients had 
thorax radiographies before hospitalization. 
The control group consisted of 20 individuals that annually had health 
tests and worked in the hospital. There was no evidence of cardiovascular, 
renal disease or systemic disease. They received the same diet and had 
frequent clinical examinations. The study protocol was registered and 
approved by ethical committees of both hospitals, and is in accordance 
with the Helsinki Declaration of 2000. All subjects agreed to participate 
in the study. 
Clinical and laboratorial parameters: The following clinical 
parameters were investigated: demographic data, pre-existing diseases 
and current drug use. A complete physical examination was performed. All 
laboratory tests were performed in the Instituto de Nefrologia do Ceará, 
on the first and second days after the diagnosis of visceral leishmaniasis. 
All studies were performed beginning at 7AM after an overnight fast, with 
patients supine for 12h. The following parameters were measured: full 
blood count, total serum proteins, albumin and globulins, serum sodium 
and uric acid; plasma renin, ACTH, cortisol, aldosterone, TSH and free 
T4. First morning urine was collected simultaneously, and serum and 
urine osmolalities were determined. A daily urine sample was collected 
with patients on their usual diets for osmolality, sodium, urea and uric 
acid determinations. A second 24h-urine sample for 17-hydroxysteroids 
determination was collected using as conservation 20 mL of hydrochloric 
acid 8M. Creatinine clearance was calculated after fluid overload with 
1500 mL of water drunk over 30 minutes. The bladder was empty and 
the time rigorously measured. There followed three periods of urine 
collection (one hour each) and mean creatinine clearance was calculated 
and adjusted to 1.73 m2 body surface area. Urinary fractional excretions 
of sodium, uric acid and urea were calculated in daily urine samples. 
Plasma ADH and serum sodium were measured simultaneously with 
serum and first morning urine osmolality determination. 
Analytic methods: Total serum proteins were determined by the 
Biuret method, and albumin by the green bromocresol technique. 
Plasmatic colloidosmotic pressure (COP) was calculated by the Landis-
Pappenheimer equation: COP (mmHg) = 2.1(TP) + 0.16 (TP)2 + 0.009 
(TP)3, where TP = serum total proteins (g/dL). Physiological limits of 
plasmatic colloidosmotic power were 25.4 ± 2.3 mm Hg26.
Serum and urinary osmolality were measured by cryoscopy with 
Precision Systems’ Osmette A, USA. Creatinine was measured using 
modified Jaffé reaction, and uric acid was determined by the uricase 
method. Serum and urinary sodium and potassium were measured by ion 
selective electrode, AVL photometer model ISE 9180, USA. TSH, free T4, 
ACTH and cortisol were measured by chemiluminescence; antidiuretic 
hormone (ADH) and aldosterone by radioimmunoassay. For urinary 
17-hydroxysteroids, the Norymberski technique was used.
Statistical analysis: Clinical and laboratorial data were expressed as 
mean ± standard deviation (SD) or percentages. Differences between two 
independent variables were evaluated using the t test or Mann-Whitney 
test as appropriate. The Epi info 2002 (Centers for Disease Control and 
Prevention) and SPSS 10.0 (SPSS Inc. Chicago, IL, USA) were used in 
all analyses. A p- value < 0.05 was considered statistically significant.
RESULTS
All patients had daily fever, persistent nonproductive cough and 
splenomegaly. No cardiac disease was detected. Tachycardia was evident 
in routine electrocardiogram during feverish periods. Chest radiographies 
reveal increased reticular pattern of pulmonar fields, accentuated at 
bibasilar regions in 37 patients (67.2%). Clinical symptoms of pneumonia 
and radiological evidences of pneumonic infiltration were seen in nine 
patients (16.4%). Only one patient had detectable ascites. Mild low 
inferior limbs edema was present in thirteen patients (23.6%).
Demographic and clinical data were compared in kala-azar patients 
and controls (Table 1). Forty seven patients were male (85.4%), with a 
mean age of 28.6 ± 11.0 years (vs. controls 28 ± 11 years, p = 0.325) 
and eight (14.5%) were female with a mean age of 17.4 ± 8.1 years (vs. 
controls 16 ± 13 years, p = 0.152). Systolic and diastolic blood pressures 
were significantly lower in male kala-azar patients than in the control 
group. For females there was no difference. Supine blood pressure, lower 
than 100/60 mmHg was detected in 22 patients (40%). No patient had 
orthostatic hypotension. Body weight was significantly lower in kala-azar 
patients (50.3 ± 8.7 vs. 63.5 ± 11.4 kg, p < 0.005). 
All patients had severe anemia with significant difference in 
hemoglobin levels in relation to control group (7.9 ± 1.4 vs.14.2 ± 
0.8 g/dL, p < 0.0001) (Table 2). Total serum proteins ranged from 
6.6 to12.1 g/dL and 20 patients (36.3%) had increased total serum 
proteins levels. All patients presented hypoalbuminemia (range 0.8-
Table 1 
Demographic and clinical data of kala-azar patients and controls
Kala-azar Controls
n = 47 n = 8 n = 17 n = 3
Sex Male Female Male Female
Age (years) 28.6 ± 11.0§ 17.1 ± 8.0§ 28.0 ± 11 16.0 ± 13.0
Systolic blood pressure (mmHg) 101.7 ± 13.3*** 91.4 ± 14.6§ 120.3 ± 6.1 72.3 ± 5.6
Diastolic blood pressure (mmHg) 62.4 ± 10.6** 52.8 ± 12.5§ 72.3 ± 5.6 65 ± 5.0
Body weight (Kg) 51.0 ± 7.8*** 39.8 ± 11.1* 63.5 ± 11.6 59.9 ± 7.9
Results expressed as mean ± SD; Descriptive level: *p < 0.05, **p < 0.005, ***p < 0.0001, § = not significant. 
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3.6 g/dL), and there was statistical difference to controls (2.5 ± 0.6 
vs. 4.6 ± 0.5 g/dL, p < 0.0001). Kala-azar patients had increased 
values of serum gammaglobulins (range 1.7-8.3 g/dL), and they 
were statistically different of controls (3.7 ± 1.6 vs.1.0 ± 0.3 g/dL, 
p < 0.0001). Intravascular colloidosmotic pressure, calculated by 
Landis-Pappenheimer equation ranged from 22.8 to 64.7 mmHg, and 
it was higher in kala-azar patients (31.2 ± 9.7 vs. 26.4 ± 1.6 mm Hg, 
p < 0.005). Twenty one patients (38.1%) had plasma colloidosmotic 
pressure in normal range (23-28 mmHg), and 34 patients (61.9%) had 
increased colloidosmotic pressure, with values above 28 mmHg. All 
patients had hyponatremia (sodium < 135 mEq/L). Serum sodium 
ranged from 120 to 134 mEq/L with a statistical difference to controls 
(129.3 ± 4.5 vs.139.4 ± 1.6 mEq/L, p < 0.0001). None of them presented 
symptoms related to hyponatremia. All patients had plasma hypo-
osmolality (Posm < 280 mOsm/kg H2O), and significant difference with 
controls (269.5 ± 8.4 vs. 290.2 ± 5.3 mOsm/kg H2O). First morning 
urine osmolality showed lower values in kala-azar patients than in 
controls (750.0 ± 52.0 vs. 894.5 ± 30.0 mOsm/kg H2O, p < 0.05), but 
they may be considered as having good urinary concentration capacity.
No patient presented urinary osmolality under 250 mOsm/kg H2O, 
showing a lack of capacity to produce diluted urine7. Urine osmolality 
was inappropriately high in relation to serum osmolality, meaning the 
persistence of ADH secretion during the whole 24-hours period. Urinary 
sodium excretion was significantly lower in kala-azar patients than in 
controls (82.3 ± 44.2 vs.110.3 ± 34.7 mEq/L, p < 0.05). No patient had 
urinary sodium concentration under 30 mEq/L. Fractional urinary sodium 
excretion (range 0.3 to 3.9%) was similar to controls: (0.9 ± 0.8 vs.0.7 
± 0.2%, p = 0.2028). Urinary potassium excretion was significantly 
lower in kala-azar patients than in controls (23.2 ± 11.1 vs. 39.4 ± 10.7 
mEq/L, p < 0.005).
Hypochloremia (serum chlorum < 96 mEq/L) was found in 17 
patients (30.9%). 
Serum urea (29.3 ± 11.3 vs. 34.7 ± 2.8 mg/dL, p < 0.005), and 24-
hour urinary urea excretion (18.2 ± 8.1 vs. 24.6 ± 6.5 g/d, p < 0.005) were 
lower in kala-azar patients than in the control group. Serum urea was 
lower than 20.0 mg/dL in 26 patients (47.2%). Fractional urinary urea 
excretion (47.3 ± 11.4 vs. 53.8 ± 15.7%, p = 0.627) was not significantly 
different to the control group. 
Serum uric acid (range1.8-6.4 mg/dL) was lower than 4.0 mg/dL in 34 
patients (61.8%)7. Mean serum uric acid (3.3 ± 1.5 vs. 4.4 ± 1.0 mg/dL, p 
< 0.005) was lower in kala-azar patients. Daily urinary uric acid excretion 
(782.7 ± 306.6 vs. 575.2 ± 185.0 mg/d, p < 0.005) was significantly higher 
in kala-azar patients. Fractional urinary uric acid excretion ranged from 6.1 
to 77%, and it was increased in 41 patients (74.5%), significantly different 
to the control group (18.7 ± 13.6 vs. 10.2 ± 3.1%, p < 0.005). 
Creatinine clearance was significantly higher in kala-azar patients 
(120.7 ± 21.4 vs. 110.4 ± 20.7 mL/min/1.73m2, p < 0.05). Patients with 
low creatinine clearances (Ccr<85 mL/min/1.73m2) were excluded due 
the presence of water and electrolyte disturbances in low renal function 
patients. Increased glomerular filtration rate (Ccr>130mL/min/1.73m2) 
was present in 14 patients (25.4%).
Plasma ADH (Table 3) measured in 23 kala-azar patients (41.8%) 
was higher than controls, but had no significant difference: (5.6 ± 1.1 vs. 
5.1 ± 3.4 pg/mL, p = 0.0635). Plasma ACTH ranged from 12 to 73 pg/
mL, and it was within the physiological range. Plasma ACTH was not 
significantly different to the control group (38.6 ± 0.09 vs. 43.2 ± 12.3 
pg/mL, p = 0.840). Eleven patients (20.0%) had normal ACTH plasma 
levels and low plasma cortisol concentrations. Plasma cortisol levels 
(range13 to 34 µg/dL) were significantly higher in kala-azar patients 
(19.0 ± 7.1 vs.14.0 ± 3.9 µg/dL, p < 0.005). Cortisol plasma levels were 
lower than 18 µg/dL in 20.0% of patients, which had low daily urinary 
17-hydroxysteroids too. Daily urinary 17-hydroxysteroids (25.5 ± 19.7 
vs. 8.8 ± 1.2 mg/d, p < 0.005) were higher in kala-azar patients and they 
were increased (> 12 mg/d) in 44 patients (80%). 
Plasma renin levels were significantly higher in kala-azar patients 
(3.1 ± 3.8 vs. 1.0 ± 0.2 ng/mL/h), p < 0.05). Plasma renin was increased 
(> 2.6 ng/mL/h) in 13 patients (23.6%). Plasma aldosterone levels were 
significantly lower in kala-azar patients (5.4 ± 3.6 vs.11.6 ± 7.2 ng/dL, 
p < 0.005). Low plasma aldosterone levels (< 3.0 ng/dL) were observed 
in 18 patients (32.7%). Daily urinary aldosterone excretion (5.9 ± 3.5 
vs. 5.5 ± 1.5 µg/d, p = 0.0623) was not significantly different to controls. 
Table 2
Laboratory findings of patients with kala-azar and controls
Kala-azar
n = 55
Controls
n = 20
Blood hemoglobin (g/dL) 7.9 ± 1.4*** 14.2 ± 0.8
Serum total proteins (g/dL) 7.8 ± 1.4§ 7.4 ± 0.4
Serum albumin (g/dL) 2.5 ± 0.6*** 4.6 ± 0.5
Serum gammaglobulins (g/L) 3.7 ± 1.6*** 1.0 ± 0.3
Plasma colloidosmotic pressure 
(mmHg)
30.7 ± 7.1 ** 26.4 ± 1.6
Serum sodium (mEq/L) 129.3 ± 4.5*** 139.4 ± 1.6
Urinary sodium (mEq/L) 82.3 ± 44.2** 110.3 ± 34.7
Serum potassium (mEq/L)  3.7 ± 0.4* 4.0 ± 0.3
Urinary potassium (mEq/L) 23.2 ± 11.1*** 39.4 ± 10.7
Serum osmotic pressure 
(mOsm/kg H2O) 
269.5 ± 8.4*** 290.2 ± 5.3
1st urine osmotic pressure 
(mOsm/kg/H2O)
750.0 ± 52.0* 894.5 ± 30.0
Serum urea (mg/dL)  29.3 ± 11.3** 34.7 ± 2.8
Urinary urea (mg/d) 18.2 ± 8.1** 24.6 ± 6.5
Fractional urea excretion (%) 47.3 ± 11.4 § 53.8 ± 15.7
Serum uric acid (mg/dL) 3.3 ± 1.5** 4.4 ± 1.0
Urinary uric acid (mg/d) 782.7 ± 306.6** 575.2 ± 185.0
Fractional urinary uric acid 
excretion (%) 
18.7 ± 13.6** 10.2 ± 3.1
Creatinine clearance 
(mL/min/1.73m2 )
120.7 ± 21.4 * 110.4 ± 20.7
Results expressed as mean ± SD; osm = osmolality ; Descriptive level: 
*p < 0.05, **p < 0.005, ***p < 0.0001, § = not significant. 
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Thirteen patients (23.6%) had high plasma renin and 42 patients 
(76.4%) had normal plasma renin concentrations (5.7 ± 4.6 vs. 1.4 ± 0.7 
ng/mL/h, p < 0.0001). Patients with high plasma renin levels had higher 
plasma aldosterone (7.2 ± 3.6 vs.3.6 ± 2.8 ng/dL, p < 0.05). They also 
had high urinary sodium concentrations (100 ± 55 vs.76 ± 39 mEq/L, p < 
0.05). There were no statistical differences between two groups, when the 
levels of serum sodium (131 ± 3.8 vs.128 ± 4.4 mEq/L), serum potassium 
(3.7 ± 0.3 vs. 3.8 ± 0.4 mEq/L), plasma coloidosmotic pressure (312 ± 
107 vs. 313 ± 92 mmHg) and fractional urinary sodium excretion (0.6 
± 0.5 vs. 0.7 ± 0.5%) were compared. Patients with increased plasma 
renin concentrations, had no evidence of extracelular volume depletion. 
Eleven patients (84.7%) with high plasma renin concentrations had 
serum uric acid below 4.0 mg/dL (4.2 ± 1.3 mg/dL) and increased uric 
acid excretion fraction (22.2 ± 18.5%), showing no difference between 
kala-azar patients with normal and with increased plasma renin levels. 
Thyroid-stimulating hormone (TSH) plasma levels of kala-azar 
patients was not statistically different (2.8 ± 2.1 vs. 2.5 ± 2.0 µIU/mL, 
p = 0.6274). Free T4 plasma levels of kala-azar patients did not show 
significant difference from the control group (1.2 ± 0.6 vs. 1.5 ± 0.3 ng/
mL, p = 0.3382). 
DISCUSSION
Daily fever, sweating, diarrhea and vomiting are present in kala-azar 
patients and may be important features to induce water and electrolyte 
disturbances. These patients manifest accentuate weight loss, but 
paradoxically preserve a good appetite during all disease evolution, 
which assures them a regular intake of fluids and sodium chloride. 
Kala-azar patients present characteristically a enormous splenomegaly, 
that induces to severe anemia, leucopenia and thrombocytopenia. Low 
blood pressure values are frequently observed in kala-azar patients, 
without evidence of orthostatic hypotension. Recently hyponatremia has 
been described in kala-azar patients of different groups20,21,25. All these 
features may be present in patients with extracellular volume depletion 
and hypovolemia. The physiological response to hypovolemia would be 
vasopressin secretion, and through the stimulus of the renin-angiotensin-
system, secondary aldosterone production.
Hyponatremic individuals, due to extra-renal causes and carriers 
of volume depletion, present low levels of urinary sodium, generally 
under 20 mEq/L8. Urinary sodium was high in all kala-azar patients, 
and fractional urinary sodium excretion stayed within the normal range, 
independently of the plasma renin concentration, ruling out the possibility 
of extracellular volume depletion. The urea excretion fraction of kala-
azar patients was similar to the control group, a physiological parameter 
frequently decreased in patients with extracellular fluid depletion. 
Nearly one fourth of kala-azar patients presented high levels of plasma 
renin, while their plasma aldosterone levels stayed in normal range, a 
possible evidence of decreased adrenal response to the high plasma renin 
levels or to the presence of a physiological block to aldosterone secretion, 
as hypokalemia, potassium depletion or expanded water space. 
Patients with high and normal plasma renin levels showed no 
difference in relation to sodium and potassium serum levels, as to daily 
urinary sodium excretion and the plasma colloidosmotic pressure values. 
Tendency to low potassium serum levels are evident in kala-azar patients 
and probably indicate the coexistence of body potassium depletion.
Carriers of low adrenal activity frequently have hyponatremia with 
high urinary sodium concentrations, and characteristically increased 
serum levels of potassium, urea and creatinine. Kala-azar patients, on 
the other side, had low plasma concentrations of aldosterone, potassium, 
urea and creatinine.
Most kala-azar patients presented plasma cortisol values higher than 
18 µg/dL11 and increased daily excretion of urinary 17-hydroxysteroids, 
assuring the presence of good adrenal function and making remote the 
possibility of adrenal insufficiency. One fifth of patients present normal 
ACTH and cortisol plasma levels with normal 17-hydroxysteroids urinary 
excretion, their real adrenal activity being difficult to evaluate. 
Blood acid-base studies in kala-azar patients had not detected the 
presence of metabolic acidosis as commonly observed in low adrenal 
activity patients21. 
Normal TSH
 
and free T4 plasma levels indicated sufficient thyroid 
hormone secretion to supply the basic needs of the organism in kala-azar 
patients, rejecting the possibility of water retention and hyponatremia, 
due to thyroid hormone deficiency. 
Hyponatremia has been also observed in malnourished patients. 
Kala-azar patients maintain an adequate food intake as observed by the 
daily urinary phosphate excretion20. Malnourished patients differ from 
kala-azar patients, particularly because they manifest reduced glomerular 
filtration rate2. 
Kala-azar patients present many features of the syndrome of 
inappropriate antidiuretic hormone secretion (SIADH). This syndrome 
is described in normovolemic or hypervolemic patients, and results in 
excessive water retention at distal and collecting ducts, despite low 
levels of extracellular fluid osmolality. Its main characteristics are: 
hyponatremia and hypo-osmolality, persistently increased urinary 
Table 3 
Laboratory findings of patients with kala-azar and controls
Kala-azar
n = 55
Controls
n = 20
ADH (pg/mL) 5.6 ± 1.1 § 5.1 ± 3.7
ACTH (pg/mL) 39.8 ± 0.2* 30.2 ± 0.3
Renin (ng/mL/h) 3.1 ± 3.8* 1.0 ± 0.2
Aldosterone (ng/dL) 5.4 ± 3.6** 11.6 ± 7.2
Cortisol (µg/dL) 19.0 ± 7.1** 14.0 ± 3.9
Urine aldosterone (µg/d) 0.2 ± 0.1§ 0.16 ± 0.04
Urine 17-hydroxysteroids (mg/d) 25.5 ± 19.7 ** 8.8 ± 1.2
TSH (µIU/mL) 2.8 ± 2.1§ 2.5 ± 2.0
T4 free(ng/mL) 1.2 ± 0.6 § 1.5 ± 0.3
ADH - antidiuretic hormone;TSH - Thyroid stimulating hormone,T4 - free thyroxin; 
Results as mean ± SD. Descriptive level: *p < 0.05, ** p < 0.005, *** p < 0.0001, 
§ 
= not significant.
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sodium excretion and urine osmolality, with preserved renal and adrenal 
functions6,30. 
Hyponatremia and hypo-osmolality were found in all patients with 
visceral leishmaniasis of the present study, and persisted throughout the 
active phase of the disease. Despite serum hypo-osmolality, kala-azar 
patients produced highly concentrated urine, as evidenced in the first 
morning samples, and in the 24-hourly urine collections. No patient had 
urine osmolality lower than 250 mOsm/kg H2O, a necessary condition 
for sufficient free water formation and aqueous diuresis production, with 
consequent plasma hypo-osmolality correction7. Kala-azar patients had 
higher plasma ADH levels. They had high urinary concentration capacity, 
but lower than that of the control group. This discrepancy may result of 
the presence of interstitial nephritis as the predominant kidney lesion of 
kala-azar patients13.
Hypoalbuminemia is part of the classical form of chronic kala-
azar, and was a constant in all kala-azar patients. It results from liver 
dysfunction, decreased albumin synthesis and reduction in intestinal 
absorption of proteins due to a protein losing enteropathy27. Low serum 
albumin concentrations decrease the plasma colloidosmotic pressure, 
and may reduce intravascular negative charges induced to lower Na+ 
attraction into vascular space (Gibbs-Donnan equilibrium), accentuating 
the hiponatremia15. 
Hypergammaglobulinemia was a typical feature of kala-azar patients, 
and results from intense production of polyclonal antibodies, particularly 
G immunoglobulins. 
Very little research has been given to the intravascular volume status 
in visceral leishmaniasis. Blood volume determinations using radio-
iron 59Fe and radio-chromium 51Cr have evidenced normal values17. 
On the other side, expanded intravascular volume has been extensively 
documented using T-1824 dye method, in patients with splenomegaly 
and visceral leishmaniasis23,31. 
In vivo and in experimental research, the calculation of plasma 
colloidosmotic pressure using the Landis-Pappenheimer equation, gives 
excellent results. The values are similar to those directly measured with 
oncometers28. The results nearly give an idea of the volemic state, when 
plasma albumin concentrations are above 1.0 g/dL, as that observed in 
the kala-azar patients24. By applying the equation, all kala-azar patients 
have normal or predominantly increased colloidosmotic pressure. The 
presence of increased plasma gammaglobulin concentrations exceed the 
decreased contribution of the hypoalbuminemia, and produce a normal or 
increased colloidosmotic pressure in kala-azar patients. The expansion of 
the intravascular volume can explain the increased values of glomerular 
filtration rate observed in kala-azar patients. 
Proximal tubular dysfunction affecting the reabsorption of proteins, 
light chains, sodium, potassium, magnesium, calcium, inorganic 
phosphate and glucose has recently been observed in kala-azar patients, 
and was also attributed to expanded water space19. Similarly, findings 
have been described in patients with different pathologies associated to 
the syndrome of inappropriate antidiuretic hormone secretion16,35. 
Increased plasma renin levels, low plasma aldosterone concentrations 
and low daily urinary aldosterone excretion were observed in one-third 
of kala-azar patients. These alterations have been described also in 
critically ill and hypotensive patients37. Total body water expansion and 
potassium depletion (vomiting, diarrhea, urinary potassium loss) may act 
as potent blocks to aldosterone secretion by adrenal glands in kala-azar 
patients. Hypochloremia and low urea serum levels may be evidence of 
decreased protein ingestion and/or body water expansion18. Hypouricemia 
and increased fractional urinary uric acid excretion are other features of 
kala-azar patients. Reduction of proximal uric acid reabsorption leads 
to increased uric acid delivery to distal and collecting ducts, resulting in 
a greater uric acid excretion1,7. 
The syndrome of antidiuretic hormone secretion in kala-azar patients 
may be started by interstitial pneumonitis described in 76.8% of necropsied 
patients12. The widespread and intensive inflammatory state involving 
the lungs, the liver, the kidneys, the intestines and the lymphatic ganglia 
induced to increase production of plasma prostaglandins and renin9,29,33,34. 
High serum levels of interleukin-6 have been detected in visceral 
leishmaniasis3,32 and can act as a potent stimulus of the hypothalamic-
pituitary-adrenal axis and to arginine vasopressin(ADH) release too14,22.
CONCLUSION
 Kala-azar patients present malnutrition, anemia, hipoalbuminemia, 
and hypergammaglobulinemia. Hyponatremia, serum hypo-osmolality 
and high urine osmolality reflect persistent antidiuretic hormone 
secretion, without production of sufficient free water for plasmatic 
hypotonicity correction. Urine sodium excretion remains comparable to 
that of normal patients. Increased urinary uric acid excretion fraction, 
hypouricemia, and the absence of adrenal and thyroid insufficiency 
suggest the possibility of the syndrome of inappropriate antidiuretic 
hormone secretion in most kala-azar patients.
RESUMO
Hiponatremia no calazar
Existem poucos relatos relacionando hiponatremia com a 
leshmaniose visceral (calazar). Este é um estudo de 55 pacientes 
portadores de calazar e um grupo controle de 20 indivíduos normais. 
Hiponatremia e hipo-osmolalidade sérica foram detectados em 100% 
dos pacientes portadores de calazar. A presença de alta osmolalidade da 
primeira urina da manhã (750,0 ± 52,0 vs. 894,5 ± 30 mOsm/Kg H2O, 
p < 0,05) e da urina de 24h (426,0 ± 167,0 vs. 514,6 ± 132,0 mOsm/Kg 
H2O, p < 0,05), demonstraram a presença de persistente secreção de 
hormônio antidiurético. A concentração de sódio urinário foi elevada 
(82,3 ± 44,2 vs. 110,3 ± 34,7 mEq/L, p < 0,05). Hipouricemia ocorreu 
em 61,8% dos pacientes e aumento da fração de excreção urinária de 
ácido úrico foi detectada em 74,5% dos casos. Aumento da velocidade de 
filtração glomerular estava presente em 25,4% dos pacientes. Não havia 
evidência clínica de depleção de volume extracelular. Valores normais de 
ADH plasmático foram observados nos pacientes com calazar. Não foi 
detectada disfunção renal ou endócrina. É provável, que a maioria dos 
pacientes com calazar apresente uma síndrome de secreção inapropriada 
de hormônio antidiurético.
ACKNOWLEDGMENTS
The authors are grateful to the team of physicians, residents, medical 
LIMA VERDE, F.A.; LIMA VERDE, F.A.A.; VERONESE, F.J.V.; NETO, A.S.; FUC, G. & LIMA VERDE, E.M. - Hyponatremia in visceral leishmaniasis. Rev. Inst. Med. Trop. Sao Paulo, 
52(5): 253-8, 2010.
258
students and nurses of Hospital São José de Doenças Infecciosas and to 
the Hospital Geral de Fortaleza for allowing the inclusion of patients in 
this study, as well as to the Instituto de Nefrologia do Ceará for technical 
and financial support.
REFERENCES
 1. Akalin E, Chandrakantan A, Keane J, Hamburger RJ. Normouricemia in the syndrome 
of inappropriate antidiuretic hormone secretion. Am J Kidney Dis. 2001;37(1): E8.
 2. Alleyne GAO.The effect of severe protein calorie malnutrition on the renal function of 
Jamaican children. Pediatrics.1967;39:400-11.
 3. Ansari NA, Saluja S, Salotra P. Elevated levels of interferon-g, interleukin-10 and 
interleukin-6 during active disease in Indian kala-azar. Clin Immunol. 2006;119:339-45.
 4. Badaró R, Duarte MIS. Leishmaniose visceral. In: Veronesi R, Focaccia R, editores. 
Tratado de infectologia. 3a ed. São Paulo: Atheneu; 2007. p. 1563-90. 
 5. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic 
hormone. Am J Med.1967;42:790-806.
 6. Baylis PH. The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem 
Cell Biol. 2003;35:1495-9.
 7. Beck LH. Hypouricemia in the syndrome of inappropriate secretion of antidiuretic 
hormone. N Engl J Med.1979;301:528-30.
 8. Berl T, Verbalis J. Disorders of water balance In: Brenner & Rector’s, editors. The kidney. 
8th ed. Boston: Saunders, 2007. p. 491-504
 9. Brandonisio O, Panaro MA, Sisto M, Acquafredda A, Fumarola L, Leogrande D, et al. 
Nitric oxide production by Leishmania-infected macrophages and modulation by 
cytoquines and prostaglandins. Parassitologia.2001;43(suppl 1):1-6. 
 10.  Carvalho EM, Barral A, Pedral-Sampaio D, Barral-Netto M, Badaró R, Rocha J, et 
al. Immunological markers of clinical evolution in children recently infected with 
Leishmania donovani chagasi. J Infect Dis.1992;165:535-40. 
 11.  Dluhy AS. Disorders of adrenal cortex. In: Fauci AS, Braunwald E, Kasper LH, 
Hauser SL, Longo Dan L, Jameson JL, Loscalzo J, editors. Harrisson’s principles of 
internal medicine. New York: Mc Graw-Hill; 2008. p. 7118-78.
 12.  Duarte MIS, Matta VLR, Corbett CEP, Lurenti MD, Chebabo R, Goto H. Interstitial 
pneumonitis in human visceral leishmaniasis. Trans R Soc Trop Med Hyg. 
1989;83:73-76.
 13.  Duarte MIS, Silva MRR, Goto H, Nicodemo EL, Amato Neto V. Interstitial nephritis 
in human kala-azar. Trans R Soc Trop Med Hyg.1983;77:531-7.
 14.  Gionis D, Ilias I, Moustaki M, Mantzos E, Papadatos I, Koutras DA, et al. 
Hypothalamic-pituitary-adrenal axis and interleukin-6 activity in children with head 
trauma and syndrome of inappropriate secretion of antidiuretic hormone. J Pediatr 
Endocrinol Metabol. 2003;16:49-54.
 15.  Halperin ML, Goldstein MB. Fluid, electrolyte and acid-base physiology. 3rd ed. 
Philadelphia: Saunders, 1999. p. 227-328.
 16.  Ishii T, Ohtake T, Yasu T, Kadotani Y, Hayashi S, Oka M, et al. A rare case of combine 
syndrome of innapropriate antidiuretic hormone secretion and Fanconi syndrome in 
an elderly woman. Am J Kidney Dis. 2006;48:155-8.
 17.  Knight R, Woodruff AW, Pettitt LE. The mechanism of anaemia in kala-azar: a study 
of 2 patients. Trans R Soc Trop Med Hyg.1967;61:701-5.
 18.  Liamis G, Christidis D, Alexandridis G, Bairaktari E, Madias NE, Elisaf M. Uric 
acid homeostasis in the evaluation of diuretic-induced hyponatremia. J Invest Med. 
2007;55:36-44.
 19.  Lima Verde FAA, Lima Verde FA, Daher EF, Santos GM, Saboia Neto A, Lima Verde 
EM. Renal tubular dysfunction in human visceral leishmaniasis (Kala-azar). Clin 
Nephrol.2009;71:492-500. 
 20.  Lima Verde FAA, Lima Verde FA, Lima Verde IA, Silva Junior GB, Daher EF, Lima 
Verde EM. Evaluation of renal function in human visceral leishmaniasis ( Kala-azar): 
a prospectivetive study on 50 patients from Brazil. J Nephol. 2007;20:430-6.
 21.  Lima Verde FA, Santos GM, Lima Verde FAA, Daher EF, Saboia Neto A, Lima Verde 
EM. Distúrbios ácido-base na leishmaniose visceral. J Bras Nefrol. 2008;30:172-179.
 22.  Mastorakos G, Weber JS, Magiakou MA, Gunnb H, Chrousos GP. Hypothalamic-
pituitary-adrenal axis and stimulation of systemic vasopressin secretion by 
recombinant Interleukin-6 in humans: potential implications for the syndrome of 
inappropriate vasopressin secretion. J Clin Endocrinol Metab.1994;79:934-9.
 23.  Mc Fadzean AJS, Todd D, Tsang KC. Observations on the anemia of criptogenetic 
splenomegaly. II. Expansion of the plasma volume. Blood. 1958;13:524-32.
 24.  Miller PL, Meyer TW. Plasma protein concentration and colloid osmotic pressure in 
nephrotic rats. Kidney Int. 1988;34:220-3.
 25.  Minodier P, Piarroux R, Garnier JM, Unal D, Perrimond H, Dumon H. Pediatric 
visceral leishmaniasis in Southern France. Pediatr Infect Dis J. 1998;17:701-4.
 26.  Morissette MP. Colloid osmotic pressure: its measurement and clinical value. Can 
Med Ass J. 1977;116:897-900. 
 27.  Muigai R, Gatei DG, Shaunak S, Wozniak A, Bryceson AD. Jejunal function and 
pathology in visceral leishmaniasis. Lancet. 1983;2:476-9.
 28.  Mullins RE, Pappas AA, Gadsden RH. Correlation of standardized serum protein 
determinations with calculated and measured colloid osmotic pressure. Am J Clin 
Path. 1983;80:170-5.
 29. Murakami T, Matoba H, Kuga Y, Ozawa S, Kubota K, Yoshida S. Hyponatremia in a 
patient in a chronic inflammatory disease. Intern Med. 1998;37:792-5.
 30. Nolph KD, Schrier RW. Sodium, potassium and water metabolism in the syndrome of 
inappropriate antidiuretic hormone secretion. Am J Med. 1970;49:534-45.
 31. Pippard MJ, Moir D, Weatherall DJ, Lenicker HM. Mechanism of anemia in resistant 
visceral leishmaniasis. Ann Trop Med Parasitol.1986;80:317-23.
 32. Poll T, Zijlstra EE, Mevissen M. Interleukin 6 during active visceral leishmaniasis and 
after treatment. Clin Immunol Immunopathol.1995;77:111-4.
 33. Reiner NE, Malemud CJ. Arachidonic acid metabolism by murine peritoneal macrophages 
infected with Leishmania donovani: in vitro evidence for parasite-induced alterations 
in ciclooxigenase and lypooxygenase pathways. J Immunol. 1985;134:556-63.
 34.  Reiner NE, Schultz LA, Malemud CJ. Eicosanoid metabolism by Leishmania 
donovani-infected macrophages: mouse strain response in prostanoid synthesis. Am 
J Trop Med Hyg. 1988;38:59-64.
 35. Rizos E, Liamis G, Elisaf M. Multiple metabolic abnormalities in a patient with the 
syndrome of inappropriate antidiuresis. Nephron. 2002;91:339-40. 
 36. Totan M, Hokelek M, Cetinkaya MC. Five pneumonia cases associated with visceral 
leishmaniasis in Turkey. Intern Pediatr. 2003;18:185-7.
 37. Zipser RD, Davenport MW, Martin KL, Tuck ML, Warner NE, Swinney RR, et al. 
Hyperreninemic hypoaldosteronism in the critically ill: a new entity. J Clin Endocrinol 
Metab. 1981;53:867-73.
 Received: 10 May 2010
 Accepted: 10 August 2010
